Revvity, Inc. Schedules 2024 Annual Meeting of Shareholders
Ticker: RVTY · Form: DEF 14A · Filed: Mar 13, 2024 · CIK: 31791
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Shareholders, DEF 14A, Revvity
TL;DR
<b>Revvity, Inc. has filed its Definitive Proxy Statement for the 2024 Annual Meeting of Shareholders.</b>
AI Summary
REVVITY, INC. (RVTY) filed a Proxy Statement (DEF 14A) with the SEC on March 13, 2024. Revvity, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 13, 2024. The filing pertains to the company's 2024 annual meeting of shareholders. The company was formerly known as PerkinElmer Inc. Revvity, Inc. is incorporated in Massachusetts (MA). The company's fiscal year ends on December 29th.
Why It Matters
For investors and stakeholders tracking REVVITY, INC., this filing contains several important signals. This DEF 14A filing provides shareholders with essential information regarding the upcoming annual meeting, including details on voting procedures and matters to be discussed. As a public document, it ensures transparency and allows shareholders to make informed decisions about company governance and proposals.
Risk Assessment
Risk Level: low — REVVITY, INC. shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate governance procedures rather than significant new developments or risks.
Analyst Insight
Review the proxy statement to understand the agenda for the 2024 annual meeting and any shareholder proposals or director elections.
Key Numbers
- 2024 — Annual Meeting Year (2024 annual meeting of shareholders)
- 2023-12-31 — Fiscal Year End (Fiscal year end date)
- 1999-11-03 — Name Change Date (Date of name change from PerkinElmer Inc.)
Key Players & Entities
- Revvity, Inc. (company) — Registrant
- PerkinElmer Inc (company) — Former company name
- EG&G Inc (company) — Former company name
- Edgerton Germeshausen & Grier Inc (company) — Former company name
- Massachusetts (location) — State of incorporation
- 2024 (date) — Annual meeting year
- March 13, 2024 (date) — Filing date
FAQ
When did REVVITY, INC. file this DEF 14A?
REVVITY, INC. filed this Proxy Statement (DEF 14A) with the SEC on March 13, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by REVVITY, INC. (RVTY).
Where can I read the original DEF 14A filing from REVVITY, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by REVVITY, INC..
What are the key takeaways from REVVITY, INC.'s DEF 14A?
REVVITY, INC. filed this DEF 14A on March 13, 2024. Key takeaways: Revvity, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 13, 2024.. The filing pertains to the company's 2024 annual meeting of shareholders.. The company was formerly known as PerkinElmer Inc..
Is REVVITY, INC. a risky investment based on this filing?
Based on this DEF 14A, REVVITY, INC. presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating standard corporate governance procedures rather than significant new developments or risks.
What should investors do after reading REVVITY, INC.'s DEF 14A?
Review the proxy statement to understand the agenda for the 2024 annual meeting and any shareholder proposals or director elections. The overall sentiment from this filing is neutral.
How does REVVITY, INC. compare to its industry peers?
Revvity, Inc. operates in the laboratory analytical instruments industry, providing solutions for life sciences and diagnostics.
Are there regulatory concerns for REVVITY, INC.?
The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.
Industry Context
Revvity, Inc. operates in the laboratory analytical instruments industry, providing solutions for life sciences and diagnostics.
Regulatory Implications
The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.
What Investors Should Do
- Review the full DEF 14A filing for details on director nominations and any shareholder proposals.
- Understand the voting procedures and deadlines for the 2024 annual meeting.
- Note the company's former names and incorporation details for historical context.
Key Dates
- 2024-04-23: 2024 Annual Meeting of Shareholders — Shareholders will vote on company matters.
- 2024-03-13: Filing Date — Definitive Proxy Statement filed with the SEC.
Year-Over-Year Comparison
This is a DEF 14A filing for the 2024 annual meeting, following the typical schedule for such corporate events.
Filing Stats: 4,692 words · 19 min read · ~16 pages · Grade level 13.4 · Accepted 2024-03-13 08:01:11
Key Financial Figures
- $1.44 — per share from continuing operations of $1.44 for fiscal year 2023, as compared to GA
- $4.06 — per share from continuing operations of $4.06 for fiscal year 2022. Adjusted earnings
- $4 — ing operations for fiscal year 2023 was $4.65, as compared to $6.92 in fiscal year
- $6.92 — cal year 2023 was $4.65, as compared to $6.92 in fiscal year 2022. GAAP revenue for
- $2,751 m — GAAP revenue for fiscal year 2023 of $2,751 million, as compared to $3,312 million in
- $3,312 million — 2023 of $2,751 million, as compared to $3,312 million in fiscal year 2022. GAAP operating i
- $301 m — uing operations for fiscal year 2023 of $301 million, as compared to $743 million in f
- $743 million — ar 2023 of $301 million, as compared to $743 million in fiscal year 2022. GAAP operating p
- $35,000 — s, and will pay Georgeson approximately $35,000 plus out-of-pocket expenses for its eff
Filing Documents
- d109956ddef14a.htm (DEF 14A) — 1727KB
- g109956g01g01.jpg (GRAPHIC) — 102KB
- g109956g02g02.jpg (GRAPHIC) — 86KB
- g109956g10p18.jpg (GRAPHIC) — 58KB
- g109956g12p37.jpg (GRAPHIC) — 60KB
- g109956g32a45.jpg (GRAPHIC) — 20KB
- g109956g32p14.jpg (GRAPHIC) — 52KB
- g109956g34t34.jpg (GRAPHIC) — 62KB
- g109956g44e62.jpg (GRAPHIC) — 20KB
- g109956g46g82.jpg (GRAPHIC) — 33KB
- g109956g65g01.jpg (GRAPHIC) — 86KB
- g109956g71p17.jpg (GRAPHIC) — 35KB
- 0001193125-24-066406.txt ( ) — 3837KB
- pki-20231231.xsd (EX-101.SCH) — 4KB
- pki-20231231_def.xml (EX-101.DEF) — 4KB
- pki-20231231_lab.xml (EX-101.LAB) — 5KB
- pki-20231231_pre.xml (EX-101.PRE) — 3KB
- d109956ddef14a_htm.xml (XML) — 147KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 27 Compensation Discussion and Analysis 27 Compensation Committee Report 47 Summary Compensation Table 48 2023 Grants of Plan-Based Awards 50 Outstanding Equity Awards at 2023 Fiscal Year-End 52 Option Exercises and Stock Vested in Fiscal Year 2023 54 2023 Non-Qualified Deferred Compensation 55 Potential Payments upon Termination or Change in Control 56 Equity Compensation Plan Information 68 CEO Pay Ratio 69 PAY VERSUS PERFORMANCE 70 PROPOSAL NO. 2 RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 74 PROPOSAL NO. 3 NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION 75 PROPOSAL NO. 4 SHAREHOLDER PROPOSAL REGARDING SIMPLE MAJORITY VOTE 76 OTHER MATTERS 79 DELINQUENT SECTION 16(a) REPORTS 79 SHAREHOLDER PROPOSALS FOR 2025 ANNUAL MEETING OF SHAREHOLDERS 79 APPENDIX A RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES A-1 APPENDIX B FORM OF PROXY CARD B-1 NOTICE OF ANNUAL MEETING To the Shareholders of Revvity, Inc.: The annual meeting of the shareholders of Revvity, Inc. will be held via a live webcast on Tuesday, April 23, 2024, at 8:00 a.m., to consider and act upon the following: 1. A proposal to elect ten nominees for director for terms of one year each; 2. A proposal to ratify the selection of Deloitte & Touche LLP as Revvity's independent registered public accounting firm for the current fiscal year; 3. A proposal to approve, by non-binding advisory vote, our executive compensation; 4. A shareholder proposal to adopt a majority voting standard, if properly presented at the annual meeting; and 5. Such other matters as may properly come before the meeting or any adjournment or postponement thereof. Our board of directors has no knowledge of any other business to be transacted at the meeting. Our board of directors has fixed the close of business on February 26, 2024 as the record date for the determination of shar